Pakistan Adopts Global Standards to Ensure Safer Medicines for Patients

A Landmark Reform in Drug Safety

In a major step toward improving public health, the Drug Regulatory Authority of Pakistan (DRAP) has officially adopted internationally recognized Good Manufacturing Practice (GMP) standards. This reform replaces outdated local regulations with the Pharmaceutical Inspection Co-operation Scheme (PIC/S) guidelines, ensuring that medicines produced in Pakistan meet global safety and quality benchmarks.

Why This Change Matters

The move is designed to protect patients by enforcing stricter controls on how medicines are manufactured. According to DRAP officials, every tablet, capsule, and injection will now be subject to rigorous international standards. This shift is expected to boost public confidence in the safety and effectiveness of locally produced drugs.

Integration with WHO Guidelines

Where PIC/S standards do not apply, the World Health Organization’s (WHO) GMP guidelines will be used. This dual approach ensures comprehensive coverage across all aspects of pharmaceutical production. Additionally, the Central Licensing Board may grant exemptions under specific circumstances to support smooth implementation.

Phased Rollout and Industry Support

The transition to the new system will be phased in over six months. DRAP has committed to working closely with pharmaceutical manufacturers to help them comply with the new standards. This collaborative approach acknowledges the complexity of the reform and aims to minimize disruption while maximizing public health benefits.

Impact on Public Health and Industry

Health experts have welcomed the reform, noting that poor-quality medicines have long posed a hidden threat to patients in Pakistan. By aligning with global GMP standards, DRAP is not only safeguarding public health but also positioning the country’s pharmaceutical industry for greater export potential.

A Turning Point for Pakistan’s Healthcare System

“This is a turning point,” said a senior DRAP representative. “For patients, it means better quality and safer treatments. For industry, it opens doors to new markets. And for Pakistan, it strengthens trust in our healthcare system”.

Conclusion: Building a Safer Future

Pakistan’s adoption of international GMP standards marks a significant milestone in its journey toward safer, more reliable healthcare. As the reform unfolds, it promises to elevate the quality of medicines, enhance patient safety, and unlock new opportunities for pharmaceutical growth.